Likatavicius G, van de Laar MJ. HIV infection and AIDS in the European Union and European Economic Area, 2010. Euro Surveill. 2011;16(48).
Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro Surveill. 2011;16(48).
European Centre for Disease Prevention and Control (ECDC)/World Health Organization (WHO) Regional Office for Europe. HIV/AIDS Surveillance in Europe 2010. Stockholm: ECDC; 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/111129_SUR_Annual_HIVReport.pdf. Last visited 30/8/2013
Istituto Superiore di Sanità. Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 DICEMBRE 2012. Notiziario ISS. 2013;26(n.9 suppl 1). (available at http://www.iss.it/binary/ccoa/cont/Dicembre_2013.pdf last visited 30/12/2013).
MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.
Article
PubMed
PubMed Central
Google Scholar
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Trends in injecting drug use in Europe. Selected issue 2011. Available from: http://www.emcdda.europa.eu/publications/selected-issues/injecting.
Wiessing L, Klempová D, Hedrich D, Montanari L, Gyarmathy VA. Injecting drug use in Europe: stable or declining. Euro Surveill. 2010;15(26).
European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC/EMCDDA; Oct 2011. Available from: http://www.ecdc.europa.eu/en/publications/Publications/111012_Guidance_ECDC-EMCDDA.pdf. Last visited 30/8/2013.
Wiessing L, van de Laar MJ, Donoghoe MC, Guarita B, Klempová D, Griffiths P. HIV among injecting drug users in Europe: increasing trends in the East. Euro Surveill. 2008;13(50).
Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill. 2011;16(48).
Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, et al. Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? Euro Surveill. 2013;18(48). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20648.
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report. Trends and development 2013. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_213154_EN_TDAT13001ENN1.pdf.
Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS. 1987;1:67–76.
CAS
PubMed
Google Scholar
Nicolosi A, Leite ML, Musicco M, Molinari S, Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. Am J Epidemiol. 1992;135:225–33.
CAS
PubMed
Google Scholar
Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.
Article
CAS
PubMed
Google Scholar
Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281–8.
Article
CAS
PubMed
Google Scholar
Des Jarlais C, Semaan S. HIV and other sexually transmitted infections in injection drug users and crack cocaine smokers. In: Holmes K, Sparling P, Stamm W, et al., editors. Sexually transmitted diseases. 4th ed. New York: McGraw Hill; 2008. p. 237–55.
Google Scholar
Urbina A, Jones K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis. 2004;38:890–4.
Article
PubMed
Google Scholar
Colfax GN, Mansergh G, Guzman R, Vittinghoff E, Marks G, Rader M, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison. JAIDS. 2001;28:373–9.
CAS
PubMed
Google Scholar
Estébanez P, Fitch K, Nájera R. HIV and female sex workers. Bull World Health Organ. 1993;71:397–412.
PubMed
PubMed Central
Google Scholar
Daskalopoulou M, Phillips A, Sherr L, Rodger A, Speakman A, Edwards S, et al. Recreational drug use and high risk sexual behaviour among HIV-diagnosed men who have sex with men (MSM) in the UK: results from the Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) study. 14th EACS, 16-19 October 2013, Brussels Oral abstract PS 11.3.
Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, et al. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Ann Ist Super Sanità. 2010;46:59–65.
Article
PubMed
Google Scholar
Neaigus A, Gyarmathy VA, Miller M, Fiedman SR, Des Jarlais DC. Sexual and other noninjection risks for HBV and HCV seroconversions among non injecting heroin users. J Infect Dis. 2007;195:1052–61.
Article
PubMed
Google Scholar
Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, Mcknight C, et al. The transition from injection to non-injection drug use: long term outcomes among heroin and cocaine users in New York City. Addiction. 2007;102:778–85.
Article
PubMed
Google Scholar
Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS. 2006;20:1771–5.
Article
PubMed
Google Scholar
Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22:278–95.
Article
PubMed
Google Scholar
Suligoi B, Camoni L, Boros S, Regine V, Pugliese L, Santaquilani M. Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2011. Not Ist Super Sanità. 2012;25(10, Suppl 1):3–47. http://www.iss.it/binary/ccoa/cont/Dicembre_2012.pdf.
Google Scholar
Vickerman P, Martin NK, Roy A, Beattie T, EMCDDA Collaborative Group, Jarlais DD, et al. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug Alcohol Depend. 2013;132:172–81.
Article
PubMed
Google Scholar
Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction. 2010;105:311–8.
Article
PubMed
Google Scholar
de Vos AS, van der Helm JJ, Prins M, Kretzschmar ME. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. Epidemics. 2012;4:57–67.
Article
PubMed
Google Scholar
Kraus L, Augustin R, Frischer M, Kümmler P, Uhl A, Wiessing L. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction. 2003;98:471–85.
Article
PubMed
Google Scholar
Camoni L, Federico B, Capelli G, Salfa MC, Regine V, Nicoletti G, et al. [Proportion of drug users in treatment who have never undergone serological testing for HIV, HBV and HCV and correlates of failure to undergo testing: Italy, 2005-2007]. Ann Ig. 2009;21:315.
CAS
PubMed
Google Scholar
Camoni L, Federico B, Capelli G, Regine V, Salfa MC, Nicoletti G, et al. Few Italian Drug Users Undergo HIV Testing. AIDS Behav. 2011;15:711–7.
Article
CAS
PubMed
Google Scholar
Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;8:CD004145.
PubMed
Google Scholar
Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014–28.
Article
PubMed
Google Scholar
Seidenberg A, Rosemann T, Senn O. Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting. BMC Infect Dis. 2013;13:9.
Article
PubMed
PubMed Central
Google Scholar
Dipartimento Politiche Antidroga: Relazione annuale al parlamento. Relazione 2012-Sintesi. Report NAZIONALE nazionale sull’uso di sostanze stupefacenti e sullo stato delle tossicodipendenze in Italia (su dati 2011 e primo semestre 2012). (available at http://www.dronet.org/monografia.php?monografie=91; last visited 03/10/2013).
Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–50.
Article
PubMed
Google Scholar
Mocroft A, Lundgren JD, Sabin ML, Monforte AD, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research europe study (COHERE). PLoS Med. 2013;10(9):e1001510.
Article
PubMed
PubMed Central
Google Scholar
Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study. J Acquir Immune Defic Syndr. 2008;47:221–5.
Article
PubMed
Google Scholar
Zucchetto A, Bruzzone S, De Paoli A, Regine V, Pappagallo M, Dal Maso L, et al. AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era. Epidemiol Prev. 2009;33:184–9.
PubMed
Google Scholar
EMCDDA. The state of the drugs problem in the European Union and Norway. Annual Report 2012. Available at http://www.emcdda.europa.eu/attachements.cfm/att_190854_EN_TDAC12001ENC_.pdf.